Stents

Stents

Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval

The Next Advance in Durable Polymer Stent Technology from Boston Scientific is Now Available in Europe and Other Select Geographies NATICK, Mass. - Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System, the company's next-generation durable polymer drug-eluting stent (DES) technology, and is...

Read More »
Catheters

Cordis Europe Signs Agreement with Volcano Europe to Provide Access to State-of-the-Art Intravascular Imaging for Use in Drug-Eluting Stent Procedures

WATERLOO, Belgium, November 8 Collaboration Focuses on Providing the Benefits of IVUS-Guided Stenting to a Wider Array of Hospitals Cordis Europe announced today a collaboration with Volcano Europe, a developer and manufacturer of intravascular ultrasound (IVUS) systems and imaging catheters, that will allow Cordis to assist hospitals in Europe to gain access to Volcano's state-of-the-art IVUS...

Read More »
Stents

Stent System treats clogged neck arteries.

Consisting of small, wire-mesh tube, PRECISE® PRO RX(TM) Nitinol Self-Expanding Stent props open blocked artery and may be used in conjunction with ANGIOGUARD® Rx Emboli Capture Guidewire System, which traps particles of plaque, blood clot, or other material that may be dislodged in carotid artery during stent placement. System is FDA and CE Mark approved to treat carotid artery...

Read More »
Stents

Boston Scientific Receives CE Mark for TAXUS® Liberte(TM) Long Stent

Longest drug-eluting stent approved for the management of patients with clinically challenging coronary artery disease NATICK, Mass., and BARCELONA, Spain, May 24 /- Boston Scientific Corporation (NYSE:BSX) today announced that it has received CE Mark for its TAXUS® Liberte(TM) Long paclitaxel-eluting coronary stent system, allowing doctors to treat longer coronary artery lesions with a single...

Read More »
Stents

Angiotech's Corporate Partner, Boston Scientific, Announces Japanese Launch of TAXUS® Express2(TM) Coronary Stent System

Reimbursement granted by National Health Insurance System VANCOUVER, May 8 // -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPI)(NASDAQ:TSX:)(NASDAQ:ANP), a global specialty pharmaceutical and medical device company, along with its corporate partner Boston Scientific Corporation (NYSE: BSX) today announced the launch of its TAXUS(R) Express2(TM) paclitaxel-eluting coronary stent system in Japan....

Read More »
Stents

New Device Granted Humanitarian Exemption to Treat Intracranial Aneurysms

CORDIS ENTERPRISE(TM) Vascular Reconstruction Device and Delivery System Receives HDE Approval from U.S. Food and Drug Administration MIAMI LAKES, Fla., May 9 -- Cordis Neurovascular, Inc. announced today that the U.S. Food and Drug Administration has granted Humanitarian Device Exemption (HDE) approval for the CORDIS ENTERPRISE(TM) Vascular Reconstruction Device and Delivery System for use with...

Read More »
Stents

Angiotech's Corporate Partner, Boston Scientific, Announces Japanese Approval for the TAXUS® Express2(TM) Stent System

VANCOUVER, April 3 - Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPI)(NASDAQ:TSX:)(NASDAQ:ANP), a global specialty pharmaceutical and medical device company, along with its corporate partner, Boston Scientific Corporation (NYSE:BSX), announced today that Boston Scientific has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) to market its TAXUS® Express2(TM)...

Read More »
Tubes and Tubing

ORLive Presents: Endovascular Repair of Descending Thoracic Aortic Aneurysm

Minimally Invasive Alternative to Open Surgery Using GORE TAG® Thoracic Endoprosthesis Surgeons from the Keck School of Medicine from the University of Southern California in Los Angeles will perform live on www.OR-Live.com an endovascular repair of a descending thoracic aortic aneurysm with the GORE TAG® Thoracic Endoprosthesis on Wednesday, September 13, 2006 at 4 PM PDT. Fred A....

Read More »
Stents

FDA-Approved Instruments treat clogged neck arteries.

PRECISE® RX (rapid exchange) Nitinol Self-Expanding Stent and ANGIOGUARD® RX Emboli Capture Guidewire System are FDA-approved to treat carotid artery disease in patients at high risk for adverse events from carotid endarterectomy (CEA). Design facilitates single-operator by providing control over manipulation of catheter and guidewire during stenting procedures.

Read More »
Stents

Boston Scientific Announces First Use of PROMUS(TM) Everolimus-Eluting Stent System

Boston Scientific only company to offer two distinct drug-eluting stent platforms NATICK, Mass., Jan. 11 // -- Boston Scientific Corporation (NYSE:BSX) today announced the international launch and first implantation of the PROMUS(TM) Everolimus-Eluting Stent, making Boston Scientific the only company to offer two distinct drug-eluting stent (DES) platforms. PROMUS is a private-labeled XIENCE(TM)...

Read More »

All Topics